A Developability-Focused Optimization Approach Allows Identification of in Vivo Fast-Acting Antimalarials: N-[3-[(Benzimidazol-2-yl)amino]propyl]amides
- 19 May 2015
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 58 (11) , 4573-4580
Abstract
Malaria continues to be a major global health problem, being particularly devastating in the African population under the age of five. Artemisinin-based combination therapies (ACTs) are the first-line treatment recommended by the WHO to treat Plasmodium falciparum malaria, but clinical resistance against them has already been reported. As a consequence, novel chemotypes are urgently needed. Herein we report a novel, in vivo active, fast-acting antimalarial chemotype based on a benzimidazole core. This discovery is the result of a medicinal chemistry plan focused on improving the developability profile of an antichlamydial chemical class previously reported by our group.Keywords
Funding Information
- GlaxoSmithKline
- Helsingin Yliopisto
- Suomen Akatemia (265481)
- Tres Cantos Open Lab Foundation (TC045)
This publication has 25 references indexed in Scilit:
- The therapeutic journey of benzimidazoles: A reviewBioorganic & Medicinal Chemistry, 2012
- Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence “Transmission Blocking” AssayPLOS ONE, 2012
- Design and Synthesis of 2-Arylbenzimidazoles and Evaluation of Their Inhibitory Effect against Chlamydia pneumoniaeJournal of Medicinal Chemistry, 2010
- Chemical genetics of Plasmodium falciparumNature, 2010
- Thousands of chemical starting points for antimalarial lead identificationNature, 2010
- Improved Murine Model of Malaria UsingPlasmodium falciparumCompetent Strains and Non-Myelodepleted NOD-scid IL2RγnullMice Engrafted with Human ErythrocytesAntimicrobial Agents and Chemotherapy, 2009
- Synthesis and antiparasitic and antifungal evaluation of 2′-arylsubstituted-1H,1′H-[2,5′]bisbenzimidazolyl-5-carboxamidinesEuropean Journal of Medicinal Chemistry, 2009
- Evidence of Artemisinin-Resistant Malaria in Western CambodiaNew England Journal of Medicine, 2008
- Quantitative measurement of Plasmodium‐infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO‐16 fluorescenceCytometry Part A, 2008
- In silicoactivity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screenProceedings of the National Academy of Sciences, 2008